Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702272 · ClinicalTrials.gov registry record
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 150,000
- Enrollment target
NCT01702272 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 150,000 participants.
The verdict
NCT01702272 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 150,000 participants
- Enrollment target
Study Summary
The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.
Interventions
- DEVICE Procleix Dengue Virus Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150,000 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01702272
The ClinicalTrials.gov registry entry for NCT01702272 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procleix Dengue Virus Assay is the first listed.
NCT01702272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01702272 about?
NCT01702272 is a clinical study titled "Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS". The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.
What is the current status of trial NCT01702272?
This trial is currently completed. The enrollment target is 150,000 participants. The study started on 2013-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01702272?
The interventions under investigation include: Procleix Dengue Virus Assay (DEVICE).
Who is sponsoring clinical trial NCT01702272?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.